Assessment of the antimalarial potential of tetraoxane WR 148999

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 5, 2000, Pages 573-578

  Vennerstrom, J L ^a   Ager A L , Jr ^a   Andersen, S L ^a   Grace, J M ^a   Wongpanich, V ^a   Angerhofer, C K ^a   Hu, J K ^a   Wesche, D L ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 DIMETHYL 7,8,15,16 TETRAOXADISPIRO[5.2.5.2]HEXADECANE; ANTIMALARIAL AGENT; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; PEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FIRST PASS EFFECT; HUMAN; HUMAN TISSUE; IC 50; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; STRUCTURE ANALYSIS; SURVIVAL TIME;

ANIMALIA; CINCHONA PUBESCENS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034468693     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.573     Document Type: Article

References (30)

1. Oxidants, oxidant drugs and malaria
2. Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy
3. Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials
4. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: Mechanism(s) of action
5. Peroxidic Antimalarials
6. Dispiro-1,2,4,5-tetraoxanes: A new class of antimalarial peroxides
7. Formulation and pharmacokinetics of artemisinin and its derivatives
8. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
9. Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults
10. High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of Pglycoprotein involvement
11. Antimalarial drug resistance and combination chemotherapy
12. Rodent malaria models
13. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
14. In vitro activities of and mechanisms of resistance to antifol antimalarial drugs
15. Plasmodium falciparum: Cloning by single-erythrocyte micromanipulation and heterogeneity in vitro
16. A method for testing for synergy with any number of agents
17. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes
18. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450
19. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography
20. Ethoxy-, pentoxy-, and benzyloxyphenoxazone and homologues: A series of substrates to distinguish between different induced cytochromes P-450
21. The deoxygenation and isomerization of artemisinin and artemether and their relevance to antimalarial action
22. The mode of action of the antimalarial artemisinin and its derivatives
23. Antimalarial synergism and antagonism
24. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites
25. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials
26. Inhibitory effect of chloroquine on the peroxidase activity of ferriprotoporphyrin IX
27. Chloroquine - Some open questions on its antimalarial mode of action and resistance
28. Synthesis and antimalarial activity of eleven dispiro-1,2,4,5-tetraoxane analogs of WR 148999. 7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups
29. Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin
30. Synthesis and antimalarial activity of sixteen dispiro-1,2,4,5-tetraoxane analogs of WR 148999: Alkyl Substituted 7,8,15,16-Tetraoxadispiro[5.2.5.2]hexadecanes